Kat Steinke

Kat Steinke

Auto-generated profile, based on publicly available information

Kat Steinke

Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2021 in mSystems
Verified
Journal Article
Open access
PDF file
KSKat Steinke
Kat Steinke
OMOmkar S. Mohite
Omkar S. Mohite
TWTilmann Weber
Tilmann Weber
AKAkos Kovacs
Akos Kovacs
Members of the B. subtilis species complex are commonly recognized producers of secondary metabolites, among those, the production of antifungals, which makes them promising biocontrol strains. While there are studies examining the distribution of well-known secondary metabolites in Bacilli , intraspecies clade-specific distribution has not been systematically reported for the B. subtilis group.

10 March 2022 in Eurosurveillance
Verified
Journal Article
Open access
JFJannik Fonager
Jannik Fonager
MBMarc Bennedbæk
Marc Bennedbæk
PBPeter Bager
Peter Bager
JWJan Wohlfahrt
Jan Wohlfahrt
KEKirsten Maren Ellegaard
Kirsten Maren Ellegaard
MRMorten Rasmussen
Morten Rasmussen
Following emergence of the SARS-CoV-2 variant Omicron in November 2021, the dominant BA.1 sub-lineage was replaced by the BA.2 sub-lineage in Denmark. We analysed the first 2,623 BA.2 cases from 29 November 2021 to 2 January 2022. No epidemiological or clinical differences were found between individuals infected with BA.1 versus BA.2. Phylogenetic analyses showed a geographic east-to-west transmission of BA.2 from the Capital Region with clusters expanding after the Christmas holidays. Mutational analysis shows distinct differences between BA.1 and BA.2.

7 September 2023 in Eurosurveillance
Verified
Journal Article
Open access
MRMorten Rasmussen
Morten Rasmussen
FMFrederik Trier Møller
Frederik Trier Møller
VGVithiagaran Gunalan
Vithiagaran Gunalan
SBSharmin Baig
Sharmin Baig
MBMarc Bennedbæk
Marc Bennedbæk
PJPikka Jokelainen
Pikka Jokelainen
We describe 10 cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant BA.2.86 detected in Denmark, including molecular characteristics and results from wastewater surveillance that indicate that the variant is circulating in the country at a low level. This new variant with many spike gene mutations was classified as a variant under monitoring by the World Health Organization on 17 August 2023. Further global monitoring of COVID-19, BA.2.86 and other SARS-CoV-2 variants is highly warranted.

28 October 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
KSKat Steinke
Kat Steinke
OMOmkar S. Mohite
Omkar S. Mohite
TWTilmann Weber
Tilmann Weber
AKAkos Kovacs
Akos Kovacs
Microbes produce a plethora of secondary metabolites that although not essential for primary metabolism benefit them to survive in the environment, communicate, and influence differentiation. Biosynthetic gene clusters (BGCs) responsible for the production of these secondary metabolites are readily identifiable on the genome sequence of bacteria. Understanding the phylogeny and distribution of BGCs helps us to predict natural product synthesis ability of new isolates. Here, we examined the inter- and intraspecies patterns of absence/presence for all BGCs identified with antiSMASH 5.0 in 310 genomes from the B. subtilis group and assigned them to defined gene cluster families (GCFs). This allowed us to establish patterns in distribution for both known and unknown products. Further, we analyzed variations in the BGC structure of particular families encoding for natural products such as plipastatin, fengycin, iturin, mycosubtilin and bacillomycin. Our detailed analysis revealed multiple GCFs that are species or clade specific and few others that are scattered within or between species, which will guide exploration of the chemodiversity within the B. subtilis group. Uniquely, we discovered that partial deletion of BGCs and frameshift mutations in selected biosynthetic genes are conserved within phylogenetically related isolates, although isolated from around the globe. Our results highlight the importance of detailed analysis of BGCs and the remarkable phylogenetically conserved errodation of secondary metabolite biosynthetic potential in the B. subtilis group. IMPORTANCE: Members of the B. subtilis species complex are commonly recognized producers of secondary metabolites, among those the production of antifungals makes them promising biocontrol strains. However, while there are studies examining the distribution of well-known B. subtilis metabolites, this has not yet been systematically reported for the group. Here, we report the complete biosynthetic potential within the Bacillus subtilis group species to explore the distribution of the biosynthetic gene clusters and to provide an exhaustive phylogenetic conservation of secondary metabolite production supporting the chemodiversity of Bacilli . We identify that certain gene clusters acquired deletions of genes and particular frame-shift mutations rendering them inactive for secondary metabolite biosynthesis, a conserved genetic trait within phylogenetically conserved clades of certain species. The overview presented will superbly guide assigning the secondary metabolite production potential of newly isolated strains based on genome sequence and phylogenetic relatedness.

1 March 2025 in Access Microbiology
Verified
Journal Article
Open access
KSKat Steinke
Kat Steinke
KTKarina Gravgaard Thomsen
Karina Gravgaard Thomsen
SHSilje Vermedal Hoegh
Silje Vermedal Hoegh
SLSanne Løkkegaard Larsen
Sanne Løkkegaard Larsen
KVKarina Kubel Vilhelmsen
Karina Kubel Vilhelmsen
TSThomas Vognbjerg Sydenham
Thomas Vognbjerg Sydenham
Background. Whole-genome sequencing of bacterial isolates is increasingly becoming routine in clinical microbiology; however, subsequent analysis often needs to be started by a bioinformatician even for comprehensive pipelines. To increase the robustness of our workflow and free up bioinformatician work hours for development and advanced analysis, we aimed to produce a robust, customizable bioinformatic pipeline for bacterial genome assembly and routine analysis results that could be initiated by non-bioinformaticians. Results. We introduce the RSYD-BASIC pipeline for bacterial isolate sequence analysis and provide a demonstration of its functionality with two datasets composed of publicly available sequences, in which comparable results are obtained in most cases. In some instances, the pipeline provided additional information, corresponding to in vitro results where these could be obtained. In routine use at our department, the pipeline has already yielded clinically relevant results, allowing us to type a variety of bacterial pathogens isolated in our clinical laboratory. We also demonstrate how RSYD-BASIC results aided in disproving a potential outbreak. Conclusion. With the RSYD-BASIC pipeline, we present a configurable reads-to-results analysis pipeline operated by non-expert users that greatly eases the investigation of potential outbreaks by expert end users. Results obtained with publicly available sequences show comparable performance to the original methods, while underlining the importance of standardized methods.

26 September 2023
Verified
Preprint
Open access
KSKat Steinke
Kat Steinke
KTKarina Gravgaard Thomsen
Karina Gravgaard Thomsen
SHSilje Vermedal Hoegh
Silje Vermedal Hoegh
SLSanne Løkkegaard Larsen
Sanne Løkkegaard Larsen
KVKarina Kubel Vilhelmsen
Karina Kubel Vilhelmsen
TSThomas Vognbjerg Sydenham
Thomas Vognbjerg Sydenham
Whole genome sequencing of bacterial isolates is increasingly becoming routine in clinical microbiology; however, subsequent analysis often needs to be started by a bioinformatician even for comprehensive pipelines. With the RSYD-BASIC pipeline, we present a reads-to-results analysis pipeline operated by non-expert users that has already yielded clinically relevant results.